Kaken Pharmaceutical Co., Ltd.
OTC: KKPCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hiroyuki Horiuchi
- Employees
- 1,135
- Headquarters
- Tokyo, Japan
- IPO year
- 2020
- Market cap
- $984.6M
- Website
- https://www.kaken.co.jp
Loading KKPCF…
Loading profile data…Frequently asked questions about KKPCF
What does Kaken Pharmaceutical Co., Ltd. (KKPCF) do?
Kaken Pharmaceutical Co., Ltd., a Tokyo-based company established in 1917, operates globally, specializing in the development, manufacture, and commercialization of a diverse array of medical products, medical devices, and agrochemicals. Its comprehensive portfolio spans various therapeutic areas. Key pharmaceutical offerings include Clenafin, a...
Where does KKPCF trade?
Kaken Pharmaceutical Co., Ltd. (KKPCF) trades on the Other OTC.
What sector is KKPCF in?
Kaken Pharmaceutical Co., Ltd. (KKPCF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Kaken Pharmaceutical Co., Ltd.?
Hiroyuki Horiuchi is the chief executive officer of Kaken Pharmaceutical Co., Ltd. (KKPCF).
Where is Kaken Pharmaceutical Co., Ltd. headquartered?
Kaken Pharmaceutical Co., Ltd. is headquartered in Japan.
Does KKPCF pay a dividend?
Yes — Kaken Pharmaceutical Co., Ltd. (KKPCF) paid a trailing twelve-month dividend of USD 1.83 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did KKPCF go public?
Kaken Pharmaceutical Co., Ltd. (KKPCF) completed its initial public offering in 2020.